

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.67162982 |
| 2 | heart process (GO:0003015) | 4.36967016 |
| 3 | heart contraction (GO:0060047) | 4.36967016 |
| 4 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.31415675 |
| 5 | positive regulation of granulocyte differentiation (GO:0030854) | 4.19397397 |
| 6 | regulation of histone H3-K27 methylation (GO:0061085) | 4.05211960 |
| 7 | kinetochore organization (GO:0051383) | 3.98878592 |
| 8 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.97879739 |
| 9 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.83304770 |
| 10 | muscle filament sliding (GO:0030049) | 3.69335030 |
| 11 | actin-myosin filament sliding (GO:0033275) | 3.69335030 |
| 12 | mitotic metaphase plate congression (GO:0007080) | 3.67208017 |
| 13 | CENP-A containing nucleosome assembly (GO:0034080) | 3.63944662 |
| 14 | neutrophil activation involved in immune response (GO:0002283) | 3.49268933 |
| 15 | IMP biosynthetic process (GO:0006188) | 3.46691795 |
| 16 | nuclear pore complex assembly (GO:0051292) | 3.43179121 |
| 17 | chromatin remodeling at centromere (GO:0031055) | 3.41110376 |
| 18 | kinetochore assembly (GO:0051382) | 3.40772556 |
| 19 | nuclear pore organization (GO:0006999) | 3.38845528 |
| 20 | actin-mediated cell contraction (GO:0070252) | 3.37079531 |
| 21 | membrane raft organization (GO:0031579) | 3.35183057 |
| 22 | mitotic sister chromatid cohesion (GO:0007064) | 3.30989570 |
| 23 | B cell receptor signaling pathway (GO:0050853) | 3.26094737 |
| 24 | megakaryocyte development (GO:0035855) | 3.25997940 |
| 25 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.23552396 |
| 26 | regulation of gamma-delta T cell activation (GO:0046643) | 3.23467114 |
| 27 | regulation of RNA export from nucleus (GO:0046831) | 3.22574513 |
| 28 | metaphase plate congression (GO:0051310) | 3.20549765 |
| 29 | telomere maintenance via recombination (GO:0000722) | 3.19244429 |
| 30 | negative T cell selection (GO:0043383) | 3.18114809 |
| 31 | negative thymic T cell selection (GO:0045060) | 3.16654576 |
| 32 | positive T cell selection (GO:0043368) | 3.16170263 |
| 33 | purine nucleobase biosynthetic process (GO:0009113) | 3.15269261 |
| 34 | mitotic recombination (GO:0006312) | 3.14022545 |
| 35 | positive thymic T cell selection (GO:0045059) | 3.13617491 |
| 36 | establishment of chromosome localization (GO:0051303) | 3.13131492 |
| 37 | definitive hemopoiesis (GO:0060216) | 3.08969505 |
| 38 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.08177078 |
| 39 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.08177078 |
| 40 | IMP metabolic process (GO:0046040) | 3.06427259 |
| 41 | pore complex assembly (GO:0046931) | 3.06410033 |
| 42 | regulation of nucleobase-containing compound transport (GO:0032239) | 3.05957826 |
| 43 | DNA replication checkpoint (GO:0000076) | 3.04519434 |
| 44 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.01930395 |
| 45 | Rap protein signal transduction (GO:0032486) | 3.01037331 |
| 46 | hypotonic response (GO:0006971) | 3.00555266 |
| 47 | T cell selection (GO:0045058) | 2.98162983 |
| 48 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.97143819 |
| 49 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.96727157 |
| 50 | DNA replication-independent nucleosome organization (GO:0034724) | 2.96727157 |
| 51 | mitotic chromosome condensation (GO:0007076) | 2.96703254 |
| 52 | ribosomal small subunit assembly (GO:0000028) | 2.95505350 |
| 53 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.93142351 |
| 54 | DNA unwinding involved in DNA replication (GO:0006268) | 2.92520690 |
| 55 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 2.89724041 |
| 56 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.89566593 |
| 57 | regulation of spindle organization (GO:0090224) | 2.87382246 |
| 58 | RNA-dependent DNA replication (GO:0006278) | 2.85313944 |
| 59 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.84536296 |
| 60 | nucleobase biosynthetic process (GO:0046112) | 2.84465672 |
| 61 | positive regulation of B cell differentiation (GO:0045579) | 2.83981611 |
| 62 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.82643237 |
| 63 | mitotic nuclear envelope disassembly (GO:0007077) | 2.81873617 |
| 64 | peptidyl-threonine modification (GO:0018210) | 2.81594511 |
| 65 | meiotic chromosome segregation (GO:0045132) | 2.81393093 |
| 66 | DNA strand elongation (GO:0022616) | 2.78358889 |
| 67 | histone exchange (GO:0043486) | 2.77539648 |
| 68 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.77213473 |
| 69 | negative regulation of cell killing (GO:0031342) | 2.77213473 |
| 70 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.77154310 |
| 71 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.77154310 |
| 72 | modulation by symbiont of host immune response (GO:0052553) | 2.77154310 |
| 73 | positive regulation by symbiont of host defense response (GO:0052509) | 2.77154310 |
| 74 | modulation by symbiont of host defense response (GO:0052031) | 2.77154310 |
| 75 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.77154310 |
| 76 | corticosteroid receptor signaling pathway (GO:0031958) | 2.76715989 |
| 77 | positive regulation of mast cell activation (GO:0033005) | 2.76178348 |
| 78 | peptidyl-threonine phosphorylation (GO:0018107) | 2.75664068 |
| 79 | thymic T cell selection (GO:0045061) | 2.73719539 |
| 80 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.73570380 |
| 81 | protein localization to kinetochore (GO:0034501) | 2.72154272 |
| 82 | viral mRNA export from host cell nucleus (GO:0046784) | 2.70810517 |
| 83 | response to peptidoglycan (GO:0032494) | 2.70349702 |
| 84 | histone H3-K4 trimethylation (GO:0080182) | 2.68659088 |
| 85 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.68165357 |
| 86 | establishment of endothelial barrier (GO:0061028) | 2.67776556 |
| 87 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.67686821 |
| 88 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 2.67658782 |
| 89 | regulation of early endosome to late endosome transport (GO:2000641) | 2.66983902 |
| 90 | regulation of granulocyte differentiation (GO:0030852) | 2.66953742 |
| 91 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.65690941 |
| 92 | protein localization to chromosome, centromeric region (GO:0071459) | 2.64994729 |
| 93 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.64763328 |
| 94 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.64763328 |
| 95 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.64763328 |
| 96 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.64120033 |
| 97 | embryonic process involved in female pregnancy (GO:0060136) | 2.63234052 |
| 98 | spindle checkpoint (GO:0031577) | 2.62734503 |
| 99 | mitotic G2/M transition checkpoint (GO:0044818) | 2.62558215 |
| 100 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.60761838 |
| 101 | positive regulation of Rap GTPase activity (GO:0032854) | 2.58721143 |
| 102 | negative regulation of phagocytosis (GO:0050765) | 2.57615525 |
| 103 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.56088486 |
| 104 | formation of translation preinitiation complex (GO:0001731) | 2.55690149 |
| 105 | cortical actin cytoskeleton organization (GO:0030866) | 2.54883477 |
| 106 | cullin deneddylation (GO:0010388) | 2.54636636 |
| 107 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.54206993 |
| 108 | ATP-dependent chromatin remodeling (GO:0043044) | 2.52699788 |
| 109 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.52342127 |
| 110 | membrane disassembly (GO:0030397) | 2.51476586 |
| 111 | nuclear envelope disassembly (GO:0051081) | 2.51476586 |
| 112 | telomere maintenance (GO:0000723) | 2.49674361 |
| 113 | response to interleukin-15 (GO:0070672) | 2.48958902 |
| 114 | T cell costimulation (GO:0031295) | 2.48942014 |
| 115 | telomere maintenance via telomere lengthening (GO:0010833) | 2.48774497 |
| 116 | positive regulation of macrophage differentiation (GO:0045651) | 2.48130799 |
| 117 | actin filament-based movement (GO:0030048) | 2.47901164 |
| 118 | DNA replication initiation (GO:0006270) | 2.47136277 |
| 119 | telomere organization (GO:0032200) | 2.46571804 |
| 120 | regulation of platelet aggregation (GO:0090330) | 2.45976878 |
| 121 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.45381959 |
| 122 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.45186390 |
| 123 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.44575157 |
| 124 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.44574487 |
| 125 | lymphocyte costimulation (GO:0031294) | 2.44444761 |
| 126 | DNA double-strand break processing (GO:0000729) | 2.44159609 |
| 127 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.43855369 |
| 128 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.43514330 |
| 129 | regulation of mast cell degranulation (GO:0043304) | 2.43302209 |
| 130 | oxidative phosphorylation (GO:0006119) | 2.43164814 |
| 131 | mitotic G2 DNA damage checkpoint (GO:0007095) | 2.42592946 |
| 132 | protein deneddylation (GO:0000338) | 2.42464074 |
| 133 | cellular extravasation (GO:0045123) | 2.42311991 |
| 134 | nerve growth factor signaling pathway (GO:0038180) | 2.41450233 |
| 135 | maturation of 5.8S rRNA (GO:0000460) | 2.41386601 |
| 136 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.41365532 |
| 137 | leukocyte aggregation (GO:0070486) | 2.41062694 |
| 138 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.41029878 |
| 139 | localization within membrane (GO:0051668) | 2.40769307 |
| 140 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.40765892 |
| 141 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.40686273 |
| 142 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.40523806 |
| 143 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.40523806 |
| 144 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.40353554 |
| 145 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.39400841 |
| 146 | Peyers patch development (GO:0048541) | 2.39400841 |
| 147 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.38237846 |
| 148 | regulation of B cell differentiation (GO:0045577) | 2.37639925 |
| 149 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.37447274 |
| 150 | proteasome assembly (GO:0043248) | 2.37037029 |
| 151 | positive regulation of leukocyte degranulation (GO:0043302) | 2.36427665 |
| 152 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.36223694 |
| 153 | DNA topological change (GO:0006265) | 2.36177149 |
| 154 | negative regulation of skeletal muscle tissue development (GO:0048642) | 2.35781369 |
| 155 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.35644235 |
| 156 | mitotic spindle checkpoint (GO:0071174) | 2.34754342 |
| 157 | positive regulation of mast cell degranulation (GO:0043306) | 2.34160825 |
| 158 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.34160825 |
| 159 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.33561676 |
| 160 | transcription initiation from RNA polymerase I promoter (GO:0006361) | 2.33456805 |
| 161 | cardiac right ventricle morphogenesis (GO:0003215) | 2.33235160 |
| 162 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.33174302 |
| 163 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.33174302 |
| 164 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.33174302 |
| 165 | hepatocyte apoptotic process (GO:0097284) | 2.32823203 |
| 166 | regulation of defense response to virus by virus (GO:0050690) | 2.32782827 |
| 167 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.32587310 |
| 168 | SMAD protein complex assembly (GO:0007183) | 2.32045109 |
| 169 | replication fork processing (GO:0031297) | 2.31985682 |
| 170 | natural killer cell differentiation (GO:0001779) | 2.31293082 |
| 171 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.30855322 |
| 172 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.30782553 |
| 173 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.30598342 |
| 174 | cell cycle G1/S phase transition (GO:0044843) | 2.30598342 |
| 175 | mitotic sister chromatid segregation (GO:0000070) | 2.29513643 |
| 176 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.29503392 |
| 177 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.29503392 |
| 178 | regulation of mitotic spindle organization (GO:0060236) | 2.29254292 |
| 179 | negative regulation of T cell mediated immunity (GO:0002710) | 2.29230445 |
| 180 | paraxial mesoderm development (GO:0048339) | 2.29145122 |
| 181 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.29074848 |
| 182 | sarcomere organization (GO:0045214) | 2.28395814 |
| 183 | histone phosphorylation (GO:0016572) | 2.28159080 |
| 184 | macrophage activation involved in immune response (GO:0002281) | 2.27782471 |
| 185 | detection of molecule of bacterial origin (GO:0032490) | 2.27042659 |
| 186 | detection of other organism (GO:0098543) | 2.26832192 |
| 187 | T cell receptor signaling pathway (GO:0050852) | 2.26814902 |
| 188 | regulation of leukocyte degranulation (GO:0043300) | 2.26766630 |
| 189 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.25583063 |
| 190 | myeloid cell development (GO:0061515) | 2.25470709 |
| 191 | protein export from nucleus (GO:0006611) | 2.25388642 |
| 192 | T cell homeostasis (GO:0043029) | 2.22009444 |
| 193 | germinal center formation (GO:0002467) | 2.21865461 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 8.25399883 |
| 2 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 4.10568310 |
| 3 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.62283761 |
| 4 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.47694401 |
| 5 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.28659224 |
| 6 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 3.24554947 |
| 7 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.21843624 |
| 8 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.04032711 |
| 9 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.78639465 |
| 10 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.64896510 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.63220367 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.62594543 |
| 13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.61820514 |
| 14 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.61165639 |
| 15 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.60108326 |
| 16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.58281984 |
| 17 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.51886571 |
| 18 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.50299265 |
| 19 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.50090409 |
| 20 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.39818714 |
| 21 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.37998364 |
| 22 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.37603814 |
| 23 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.37182188 |
| 24 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.36265888 |
| 25 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.32148165 |
| 26 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.30828623 |
| 27 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.26695771 |
| 28 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.24126549 |
| 29 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.23734510 |
| 30 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.20843464 |
| 31 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.11916708 |
| 32 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.11755573 |
| 33 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.10639808 |
| 34 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.07178687 |
| 35 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.03988384 |
| 36 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.99431189 |
| 37 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.96553037 |
| 38 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.96382908 |
| 39 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.96051039 |
| 40 | * MYB_26560356_Chip-Seq_TH1_Human | 1.92380827 |
| 41 | GATA1_22025678_ChIP-Seq_K562_Human | 1.90153250 |
| 42 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.88349828 |
| 43 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.88102462 |
| 44 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.86673109 |
| 45 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.86603049 |
| 46 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.85300763 |
| 47 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.85090679 |
| 48 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.84163372 |
| 49 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.83632856 |
| 50 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.82415206 |
| 51 | SPI1_23127762_ChIP-Seq_K562_Human | 1.79225402 |
| 52 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.75656027 |
| 53 | * MAF_26560356_Chip-Seq_TH1_Human | 1.74738127 |
| 54 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.72606772 |
| 55 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.71815024 |
| 56 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.70116185 |
| 57 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.69451617 |
| 58 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.67707535 |
| 59 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.64589940 |
| 60 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.59727927 |
| 61 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.56775765 |
| 62 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.56722944 |
| 63 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.55605575 |
| 64 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.55577320 |
| 65 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.55280847 |
| 66 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.54490833 |
| 67 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.50071923 |
| 68 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.49787281 |
| 69 | GATA1_19941826_ChIP-Seq_K562_Human | 1.48882649 |
| 70 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.48798018 |
| 71 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.47527575 |
| 72 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.47078784 |
| 73 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.46732786 |
| 74 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.44687707 |
| 75 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.43662501 |
| 76 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.42802233 |
| 77 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.40836543 |
| 78 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.39653139 |
| 79 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.38770911 |
| 80 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.37842594 |
| 81 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.36396954 |
| 82 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.35654166 |
| 83 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.35492108 |
| 84 | * ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.35251152 |
| 85 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.34653022 |
| 86 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.34367401 |
| 87 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.34041881 |
| 88 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.32721911 |
| 89 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.32063801 |
| 90 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.31611218 |
| 91 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.31511103 |
| 92 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.30883361 |
| 93 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.30815766 |
| 94 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.30799970 |
| 95 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.30075113 |
| 96 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.29004721 |
| 97 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.28566460 |
| 98 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.27587480 |
| 99 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.26190650 |
| 100 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.25175953 |
| 101 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.24913646 |
| 102 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.23179594 |
| 103 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.22678771 |
| 104 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.21822698 |
| 105 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.20811289 |
| 106 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.20226168 |
| 107 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.19449666 |
| 108 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.17466936 |
| 109 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.15257829 |
| 110 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.14908513 |
| 111 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14400332 |
| 112 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.13151294 |
| 113 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.12968801 |
| 114 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.12923920 |
| 115 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.12322419 |
| 116 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.11628226 |
| 117 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.10979900 |
| 118 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.10634942 |
| 119 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.09562319 |
| 120 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.09256371 |
| 121 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.09226808 |
| 122 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.08419546 |
| 123 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.08010717 |
| 124 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.07752401 |
| 125 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.07689684 |
| 126 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.07024575 |
| 127 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.06364916 |
| 128 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.06266438 |
| 129 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.06087281 |
| 130 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.04308554 |
| 131 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03418659 |
| 132 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.03406614 |
| 133 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.03124329 |
| 134 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.01930615 |
| 135 | * FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.01622488 |
| 136 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.01022558 |
| 137 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.00688728 |
| 138 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.99801531 |
| 139 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99581521 |
| 140 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.99344951 |
| 141 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99154784 |
| 142 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.97369241 |
| 143 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.97098598 |
| 144 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.96623322 |
| 145 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.95071305 |
| 146 | * MAF_26560356_Chip-Seq_TH2_Human | 0.95041135 |
| 147 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.94785374 |
| 148 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.94765934 |
| 149 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.94738795 |
| 150 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.94492056 |
| 151 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.94156063 |
| 152 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.93866657 |
| 153 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.93540177 |
| 154 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.93535299 |
| 155 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.93113284 |
| 156 | * SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.91318709 |
| 157 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.89786624 |
| 158 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.87099009 |
| 159 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.86291890 |
| 160 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.85728493 |
| 161 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.85728493 |
| 162 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.85679779 |
| 163 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.84673400 |
| 164 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.84638762 |
| 165 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.84220216 |
| 166 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.81390141 |
| 167 | * MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.80968516 |
| 168 | MYC_22102868_ChIP-Seq_BL_Human | 0.80620620 |
| 169 | * MYB_26560356_Chip-Seq_TH2_Human | 0.80345111 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002877_abnormal_melanocyte_morpholog | 3.10101215 |
| 2 | MP0003693_abnormal_embryo_hatching | 2.88585068 |
| 3 | MP0008007_abnormal_cellular_replicative | 2.80498106 |
| 4 | MP0003300_gastrointestinal_ulcer | 2.68014749 |
| 5 | MP0010094_abnormal_chromosome_stability | 2.61921686 |
| 6 | MP0003077_abnormal_cell_cycle | 2.51894085 |
| 7 | MP0005464_abnormal_platelet_physiology | 2.50974608 |
| 8 | MP0002166_altered_tumor_susceptibility | 2.39173674 |
| 9 | MP0003111_abnormal_nucleus_morphology | 2.31303227 |
| 10 | MP0008057_abnormal_DNA_replication | 2.21794901 |
| 11 | MP0003123_paternal_imprinting | 2.20600374 |
| 12 | MP0003705_abnormal_hypodermis_morpholog | 2.14004493 |
| 13 | MP0004957_abnormal_blastocyst_morpholog | 2.09949253 |
| 14 | MP0008058_abnormal_DNA_repair | 2.00439942 |
| 15 | MP0003567_abnormal_fetal_cardiomyocyte | 2.00065522 |
| 16 | MP0000685_abnormal_immune_system | 1.86606990 |
| 17 | MP0003121_genomic_imprinting | 1.83005720 |
| 18 | MP0000749_muscle_degeneration | 1.82918100 |
| 19 | MP0000703_abnormal_thymus_morphology | 1.76406325 |
| 20 | MP0003091_abnormal_cell_migration | 1.75103709 |
| 21 | MP0004185_abnormal_adipocyte_glucose | 1.68422120 |
| 22 | MP0002396_abnormal_hematopoietic_system | 1.67569795 |
| 23 | MP0001800_abnormal_humoral_immune | 1.66492377 |
| 24 | MP0003941_abnormal_skin_development | 1.66019536 |
| 25 | MP0003436_decreased_susceptibility_to | 1.65891345 |
| 26 | MP0002006_tumorigenesis | 1.65324937 |
| 27 | MP0008438_abnormal_cutaneous_collagen | 1.62979458 |
| 28 | MP0005408_hypopigmentation | 1.61974006 |
| 29 | MP0005000_abnormal_immune_tolerance | 1.58778912 |
| 30 | MP0004808_abnormal_hematopoietic_stem | 1.58502012 |
| 31 | MP0003950_abnormal_plasma_membrane | 1.56050758 |
| 32 | MP0001835_abnormal_antigen_presentation | 1.55998537 |
| 33 | MP0004084_abnormal_cardiac_muscle | 1.53587226 |
| 34 | MP0003656_abnormal_erythrocyte_physiolo | 1.52030962 |
| 35 | MP0003828_pulmonary_edema | 1.51312561 |
| 36 | MP0009053_abnormal_anal_canal | 1.50888058 |
| 37 | MP0003303_peritoneal_inflammation | 1.50330821 |
| 38 | MP0002420_abnormal_adaptive_immunity | 1.44694957 |
| 39 | MP0003786_premature_aging | 1.44529922 |
| 40 | MP0008932_abnormal_embryonic_tissue | 1.44051827 |
| 41 | MP0004947_skin_inflammation | 1.43662790 |
| 42 | MP0003279_aneurysm | 1.42797353 |
| 43 | MP0001819_abnormal_immune_cell | 1.41224871 |
| 44 | MP0005076_abnormal_cell_differentiation | 1.40371455 |
| 45 | MP0000350_abnormal_cell_proliferation | 1.39647895 |
| 46 | MP0009697_abnormal_copulation | 1.39481547 |
| 47 | MP0002419_abnormal_innate_immunity | 1.38769327 |
| 48 | MP0003724_increased_susceptibility_to | 1.37357002 |
| 49 | MP0001730_embryonic_growth_arrest | 1.36814253 |
| 50 | MP0000516_abnormal_urinary_system | 1.35987147 |
| 51 | MP0005367_renal/urinary_system_phenotyp | 1.35987147 |
| 52 | MP0005409_darkened_coat_color | 1.35921416 |
| 53 | MP0002088_abnormal_embryonic_growth/wei | 1.35257952 |
| 54 | MP0002723_abnormal_immune_serum | 1.34296499 |
| 55 | MP0003984_embryonic_growth_retardation | 1.33968666 |
| 56 | MP0001851_eye_inflammation | 1.33286154 |
| 57 | MP0000716_abnormal_immune_system | 1.33170196 |
| 58 | MP0003221_abnormal_cardiomyocyte_apopto | 1.32978721 |
| 59 | MP0003315_abnormal_perineum_morphology | 1.31989158 |
| 60 | MP0005503_abnormal_tendon_morphology | 1.31842967 |
| 61 | MP0010030_abnormal_orbit_morphology | 1.31587507 |
| 62 | MP0001672_abnormal_embryogenesis/_devel | 1.31347631 |
| 63 | MP0005380_embryogenesis_phenotype | 1.31347631 |
| 64 | MP0008260_abnormal_autophagy | 1.31304324 |
| 65 | MP0003186_abnormal_redox_activity | 1.30957653 |
| 66 | MP0001790_abnormal_immune_system | 1.28883566 |
| 67 | MP0005387_immune_system_phenotype | 1.28883566 |
| 68 | MP0008877_abnormal_DNA_methylation | 1.27479697 |
| 69 | MP0002429_abnormal_blood_cell | 1.23839891 |
| 70 | MP0003763_abnormal_thymus_physiology | 1.22311841 |
| 71 | MP0003943_abnormal_hepatobiliary_system | 1.21956558 |
| 72 | MP0010155_abnormal_intestine_physiology | 1.20448906 |
| 73 | MP0002405_respiratory_system_inflammati | 1.19599158 |
| 74 | MP0003045_fibrosis | 1.18385038 |
| 75 | MP0010234_abnormal_vibrissa_follicle | 1.17318369 |
| 76 | MP0003191_abnormal_cellular_cholesterol | 1.14715175 |
| 77 | MP0002972_abnormal_cardiac_muscle | 1.13832465 |
| 78 | MP0005666_abnormal_adipose_tissue | 1.13446477 |
| 79 | MP0005451_abnormal_body_composition | 1.13014612 |
| 80 | MP0009333_abnormal_splenocyte_physiolog | 1.12105002 |
| 81 | MP0001697_abnormal_embryo_size | 1.11481486 |
| 82 | MP0000569_abnormal_digit_pigmentation | 1.11030656 |
| 83 | MP0004381_abnormal_hair_follicle | 1.10554492 |
| 84 | MP0005025_abnormal_response_to | 1.10225504 |
| 85 | MP0002132_abnormal_respiratory_system | 1.09512604 |
| 86 | MP0010630_abnormal_cardiac_muscle | 1.08990631 |
| 87 | MP0003942_abnormal_urinary_system | 1.07743002 |
| 88 | MP0001879_abnormal_lymphatic_vessel | 1.07714889 |
| 89 | MP0000015_abnormal_ear_pigmentation | 1.07157597 |
| 90 | MP0001873_stomach_inflammation | 1.05879464 |
| 91 | MP0003122_maternal_imprinting | 1.04939496 |
| 92 | MP0002998_abnormal_bone_remodeling | 1.04807914 |
| 93 | MP0004233_abnormal_muscle_weight | 1.04439533 |
| 94 | MP0003718_maternal_effect | 1.04386932 |
| 95 | MP0004197_abnormal_fetal_growth/weight/ | 1.04213595 |
| 96 | MP0006054_spinal_hemorrhage | 1.03328259 |
| 97 | MP0010352_gastrointestinal_tract_polyps | 1.03143526 |
| 98 | MP0008789_abnormal_olfactory_epithelium | 1.02454760 |
| 99 | MP0005621_abnormal_cell_physiology | 1.02149162 |
| 100 | MP0001119_abnormal_female_reproductive | 1.01381498 |
| 101 | MP0000490_abnormal_crypts_of | 1.01337462 |
| 102 | MP0000767_abnormal_smooth_muscle | 1.01263249 |
| 103 | MP0002086_abnormal_extraembryonic_tissu | 1.00671400 |
| 104 | MP0006082_CNS_inflammation | 0.98810325 |
| 105 | MP0003448_altered_tumor_morphology | 0.97947067 |
| 106 | MP0000343_altered_response_to | 0.97702118 |
| 107 | MP0001544_abnormal_cardiovascular_syste | 0.97519512 |
| 108 | MP0005385_cardiovascular_system_phenoty | 0.97519512 |
| 109 | MP0003115_abnormal_respiratory_system | 0.97104086 |
| 110 | MP0003385_abnormal_body_wall | 0.96037016 |
| 111 | MP0000566_synostosis | 0.95330551 |
| 112 | MP0001545_abnormal_hematopoietic_system | 0.95224569 |
| 113 | MP0005397_hematopoietic_system_phenotyp | 0.95224569 |
| 114 | MP0005671_abnormal_response_to | 0.94303414 |
| 115 | MP0004782_abnormal_surfactant_physiolog | 0.94145180 |
| 116 | MP0009250_abnormal_appendicular_skeleto | 0.93329211 |
| 117 | MP0000313_abnormal_cell_death | 0.93200827 |
| 118 | MP0002148_abnormal_hypersensitivity_rea | 0.92942508 |
| 119 | MP0005023_abnormal_wound_healing | 0.92070701 |
| 120 | MP0002398_abnormal_bone_marrow | 0.90913217 |
| 121 | MP0004510_myositis | 0.90886448 |
| 122 | MP0002019_abnormal_tumor_incidence | 0.90644081 |
| 123 | MP0009785_altered_susceptibility_to | 0.89582945 |
| 124 | MP0004130_abnormal_muscle_cell | 0.88058968 |
| 125 | MP0003566_abnormal_cell_adhesion | 0.87229080 |
| 126 | MP0001853_heart_inflammation | 0.87002629 |
| 127 | MP0009384_cardiac_valve_regurgitation | 0.86982144 |
| 128 | MP0001915_intracranial_hemorrhage | 0.86720292 |
| 129 | MP0003866_abnormal_defecation | 0.86669210 |
| 130 | MP0010307_abnormal_tumor_latency | 0.86569790 |
| 131 | MP0000689_abnormal_spleen_morphology | 0.86373927 |
| 132 | MP0004883_abnormal_blood_vessel | 0.86343182 |
| 133 | MP0005620_abnormal_muscle_contractility | 0.86047966 |
| 134 | MP0004087_abnormal_muscle_fiber | 0.86018315 |
| 135 | MP0002009_preneoplasia | 0.83910323 |
| 136 | MP0002085_abnormal_embryonic_tissue | 0.82223856 |
| 137 | MP0002452_abnormal_antigen_presenting | 0.82180326 |
| 138 | MP0000465_gastrointestinal_hemorrhage | 0.82176614 |
| 139 | MP0003937_abnormal_limbs/digits/tail_de | 0.82124314 |
| 140 | MP0002080_prenatal_lethality | 0.81955656 |
| 141 | MP0005275_abnormal_skin_tensile | 0.81918038 |
| 142 | MP0004036_abnormal_muscle_relaxation | 0.81627888 |
| 143 | MP0009115_abnormal_fat_cell | 0.81140036 |
| 144 | MP0005083_abnormal_biliary_tract | 0.80500738 |
| 145 | MP0002722_abnormal_immune_system | 0.80048823 |
| 146 | MP0002933_joint_inflammation | 0.79535776 |
| 147 | MP0005248_abnormal_Harderian_gland | 0.79481082 |
| 148 | MP0001845_abnormal_inflammatory_respons | 0.79473279 |
| 149 | MP0005330_cardiomyopathy | 0.79401729 |
| 150 | MP0010368_abnormal_lymphatic_system | 0.79375297 |
| 151 | MP0000858_altered_metastatic_potential | 0.79185606 |
| 152 | MP0001348_abnormal_lacrimal_gland | 0.78521299 |
| 153 | MP0003453_abnormal_keratinocyte_physiol | 0.77872889 |
| 154 | MP0004484_altered_response_of | 0.77481770 |
| 155 | MP0005058_abnormal_lysosome_morphology | 0.76640307 |
| 156 | MP0005508_abnormal_skeleton_morphology | 0.75874602 |
| 157 | MP0000733_abnormal_muscle_development | 0.75733188 |
| 158 | MP0009672_abnormal_birth_weight | 0.75601656 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Syringomyelia (HP:0003396) | 3.99463175 |
| 2 | Spinal cord lesions (HP:0100561) | 3.99463175 |
| 3 | Degeneration of anterior horn cells (HP:0002398) | 3.68107375 |
| 4 | Abnormality of the anterior horn cell (HP:0006802) | 3.68107375 |
| 5 | Fatigue (HP:0012378) | 3.35321287 |
| 6 | Prolonged bleeding time (HP:0003010) | 3.13079262 |
| 7 | Birth length less than 3rd percentile (HP:0003561) | 3.03202222 |
| 8 | Exercise-induced muscle cramps (HP:0003710) | 3.03160337 |
| 9 | Ankyloglossia (HP:0010296) | 2.96283700 |
| 10 | Osteolytic defects of the hand bones (HP:0009699) | 2.89517006 |
| 11 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.89517006 |
| 12 | T lymphocytopenia (HP:0005403) | 2.87436339 |
| 13 | Abnormal platelet volume (HP:0011876) | 2.85627056 |
| 14 | Spontaneous hematomas (HP:0007420) | 2.84658481 |
| 15 | Asymmetry of the thorax (HP:0001555) | 2.80148770 |
| 16 | Nemaline bodies (HP:0003798) | 2.79437912 |
| 17 | Increased mean platelet volume (HP:0011877) | 2.77283016 |
| 18 | Abnormality of T cell number (HP:0011839) | 2.71979499 |
| 19 | Recurrent viral infections (HP:0004429) | 2.67997880 |
| 20 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.67261171 |
| 21 | Subaortic stenosis (HP:0001682) | 2.67261171 |
| 22 | Autoimmune hemolytic anemia (HP:0001890) | 2.67058671 |
| 23 | Eczematoid dermatitis (HP:0000976) | 2.57738418 |
| 24 | Abnormal lung lobation (HP:0002101) | 2.55413167 |
| 25 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.55301126 |
| 26 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.52718741 |
| 27 | Patellar aplasia (HP:0006443) | 2.50745481 |
| 28 | Macroorchidism (HP:0000053) | 2.48698734 |
| 29 | Cutaneous melanoma (HP:0012056) | 2.47770133 |
| 30 | Deep philtrum (HP:0002002) | 2.46769338 |
| 31 | Muscle fiber inclusion bodies (HP:0100299) | 2.46277112 |
| 32 | Abnormality of oral frenula (HP:0000190) | 2.45379511 |
| 33 | Polycythemia (HP:0001901) | 2.43891192 |
| 34 | Epistaxis (HP:0000421) | 2.43077380 |
| 35 | Hyporeflexia of lower limbs (HP:0002600) | 2.42803153 |
| 36 | Abnormality of incisor morphology (HP:0011063) | 2.40638749 |
| 37 | Long clavicles (HP:0000890) | 2.37894333 |
| 38 | Embryonal renal neoplasm (HP:0011794) | 2.34733452 |
| 39 | Menorrhagia (HP:0000132) | 2.32712263 |
| 40 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.31953674 |
| 41 | Granulocytopenia (HP:0001913) | 2.30445727 |
| 42 | Papilledema (HP:0001085) | 2.28549280 |
| 43 | Cellulitis (HP:0100658) | 2.28482018 |
| 44 | Recurrent abscess formation (HP:0002722) | 2.27892641 |
| 45 | Abnormal platelet function (HP:0011869) | 2.20972124 |
| 46 | Impaired platelet aggregation (HP:0003540) | 2.20972124 |
| 47 | Panhypogammaglobulinemia (HP:0003139) | 2.19998667 |
| 48 | Pulmonary artery stenosis (HP:0004415) | 2.19000872 |
| 49 | Dilatation of the ascending aorta (HP:0005111) | 2.18594894 |
| 50 | 11 pairs of ribs (HP:0000878) | 2.18284839 |
| 51 | Slow saccadic eye movements (HP:0000514) | 2.17586213 |
| 52 | Calf muscle hypertrophy (HP:0008981) | 2.16936108 |
| 53 | Diastasis recti (HP:0001540) | 2.16618594 |
| 54 | Viral hepatitis (HP:0006562) | 2.16586669 |
| 55 | Osteomyelitis (HP:0002754) | 2.16419448 |
| 56 | Recurrent bacterial skin infections (HP:0005406) | 2.14928978 |
| 57 | Ectopic kidney (HP:0000086) | 2.14852082 |
| 58 | Gingival bleeding (HP:0000225) | 2.13739615 |
| 59 | Relative macrocephaly (HP:0004482) | 2.12703737 |
| 60 | Spondylolisthesis (HP:0003302) | 2.12252611 |
| 61 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.11985093 |
| 62 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.11226980 |
| 63 | Insidious onset (HP:0003587) | 2.10789568 |
| 64 | Termporal pattern (HP:0011008) | 2.10789568 |
| 65 | Renal cortical cysts (HP:0000803) | 2.10758625 |
| 66 | Recurrent fungal infections (HP:0002841) | 2.10120849 |
| 67 | Adrenal hypoplasia (HP:0000835) | 2.09485795 |
| 68 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.09164051 |
| 69 | Chest pain (HP:0100749) | 2.08565153 |
| 70 | Papillary thyroid carcinoma (HP:0002895) | 2.08030927 |
| 71 | Chromsome breakage (HP:0040012) | 2.07404264 |
| 72 | Breast hypoplasia (HP:0003187) | 2.06047020 |
| 73 | Arterial tortuosity (HP:0005116) | 2.03756306 |
| 74 | Lipoatrophy (HP:0100578) | 1.99890842 |
| 75 | Abnormal pancreas size (HP:0012094) | 1.99648868 |
| 76 | Carpal bone hypoplasia (HP:0001498) | 1.98912404 |
| 77 | Patent foramen ovale (HP:0001655) | 1.98550957 |
| 78 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.97423844 |
| 79 | Optic nerve coloboma (HP:0000588) | 1.97275125 |
| 80 | Periauricular skin pits (HP:0100277) | 1.96555110 |
| 81 | Preauricular pit (HP:0004467) | 1.96555110 |
| 82 | Abnormality of B cell number (HP:0010975) | 1.96464070 |
| 83 | Abnormality of the calcaneus (HP:0008364) | 1.93530267 |
| 84 | Meningitis (HP:0001287) | 1.93122808 |
| 85 | B lymphocytopenia (HP:0010976) | 1.92862505 |
| 86 | Neoplasm of the adrenal cortex (HP:0100641) | 1.91445719 |
| 87 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.91185248 |
| 88 | Short 4th metacarpal (HP:0010044) | 1.91185248 |
| 89 | Meckel diverticulum (HP:0002245) | 1.89783669 |
| 90 | Arterial thrombosis (HP:0004420) | 1.89521104 |
| 91 | Aortic aneurysm (HP:0004942) | 1.89493052 |
| 92 | Petechiae (HP:0000967) | 1.89026802 |
| 93 | Hypoplastic left heart (HP:0004383) | 1.88520997 |
| 94 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.88351962 |
| 95 | Mesomelia (HP:0003027) | 1.88304965 |
| 96 | Eosinophilia (HP:0001880) | 1.87421201 |
| 97 | Poor head control (HP:0002421) | 1.86960707 |
| 98 | Impulsivity (HP:0100710) | 1.86960225 |
| 99 | Hepatoblastoma (HP:0002884) | 1.86800677 |
| 100 | Neoplasm of the adrenal gland (HP:0100631) | 1.86355361 |
| 101 | Keratoconjunctivitis sicca (HP:0001097) | 1.85711310 |
| 102 | Colitis (HP:0002583) | 1.84601578 |
| 103 | Prominent nose (HP:0000448) | 1.84298590 |
| 104 | Vascular tortuosity (HP:0004948) | 1.84101271 |
| 105 | Dysmetric saccades (HP:0000641) | 1.82330468 |
| 106 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.81438591 |
| 107 | Short middle phalanx of the 5th finger (HP:0004220) | 1.81069497 |
| 108 | Rectal fistula (HP:0100590) | 1.80525664 |
| 109 | Rectovaginal fistula (HP:0000143) | 1.80525664 |
| 110 | Conjunctival telangiectasia (HP:0000524) | 1.80276835 |
| 111 | Gastrointestinal infarctions (HP:0005244) | 1.80189799 |
| 112 | Obstructive lung disease (HP:0006536) | 1.79294785 |
| 113 | Chronic obstructive pulmonary disease (HP:0006510) | 1.79294785 |
| 114 | Distal lower limb muscle weakness (HP:0009053) | 1.79111934 |
| 115 | Abnormality of macrophages (HP:0004311) | 1.78806706 |
| 116 | Abnormality of the common coagulation pathway (HP:0010990) | 1.78540681 |
| 117 | Intestinal fistula (HP:0100819) | 1.78193866 |
| 118 | Amaurosis fugax (HP:0100576) | 1.77488454 |
| 119 | Type 1 muscle fiber predominance (HP:0003803) | 1.77042665 |
| 120 | Sparse lateral eyebrow (HP:0005338) | 1.76761238 |
| 121 | Optic neuritis (HP:0100653) | 1.76002902 |
| 122 | Retrobulbar optic neuritis (HP:0100654) | 1.76002902 |
| 123 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.75634156 |
| 124 | Calcaneovalgus deformity (HP:0001848) | 1.75376265 |
| 125 | Abnormality of the incisor (HP:0000676) | 1.75241615 |
| 126 | IgA deficiency (HP:0002720) | 1.75019573 |
| 127 | Somatic mutation (HP:0001428) | 1.74966326 |
| 128 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.74765633 |
| 129 | Abnormality of T cells (HP:0002843) | 1.74655357 |
| 130 | Hypoplastic heart (HP:0001961) | 1.74354279 |
| 131 | Subacute progressive viral hepatitis (HP:0006572) | 1.73649986 |
| 132 | Abnormality of the fingertips (HP:0001211) | 1.73571222 |
| 133 | Thyroid carcinoma (HP:0002890) | 1.73202174 |
| 134 | Deviation of the thumb (HP:0009603) | 1.73166281 |
| 135 | Abnormality of chromosome stability (HP:0003220) | 1.73052218 |
| 136 | Acute myeloid leukemia (HP:0004808) | 1.73042670 |
| 137 | Prolonged neonatal jaundice (HP:0006579) | 1.71449565 |
| 138 | Autoamputation (HP:0001218) | 1.71421761 |
| 139 | Abnormality of the intervertebral disk (HP:0005108) | 1.71382637 |
| 140 | Colon cancer (HP:0003003) | 1.71267387 |
| 141 | Vasculitis (HP:0002633) | 1.71116861 |
| 142 | Coarctation of aorta (HP:0001680) | 1.71116201 |
| 143 | Abnormality of the ileum (HP:0001549) | 1.70754734 |
| 144 | Increased variability in muscle fiber diameter (HP:0003557) | 1.70258934 |
| 145 | Glucose intolerance (HP:0000833) | 1.69973478 |
| 146 | Difficulty running (HP:0009046) | 1.69211278 |
| 147 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.69079088 |
| 148 | Meningioma (HP:0002858) | 1.68878664 |
| 149 | Absent frontal sinuses (HP:0002688) | 1.68525700 |
| 150 | Cystic hygroma (HP:0000476) | 1.67549943 |
| 151 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.66722195 |
| 152 | Keratoconjunctivitis (HP:0001096) | 1.66636769 |
| 153 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.66628027 |
| 154 | Recurrent cutaneous fungal infections (HP:0011370) | 1.63931470 |
| 155 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.63931470 |
| 156 | Distal lower limb amyotrophy (HP:0008944) | 1.63525232 |
| 157 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.62617066 |
| 158 | Nausea (HP:0002018) | 1.62347991 |
| 159 | Abnormal biliary tract morphology (HP:0012440) | 1.62202807 |
| 160 | Abnormality of the metopic suture (HP:0005556) | 1.61511966 |
| 161 | Sandal gap (HP:0001852) | 1.60907160 |
| 162 | Bladder neoplasm (HP:0009725) | 1.60737317 |
| 163 | Bladder carcinoma (HP:0002862) | 1.60737317 |
| 164 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.60402877 |
| 165 | Menstrual irregularities (HP:0000858) | 1.60018893 |
| 166 | Acute lymphatic leukemia (HP:0006721) | 1.59947668 |
| 167 | Thrombocytosis (HP:0001894) | 1.59110095 |
| 168 | Deformed tarsal bones (HP:0008119) | 1.58700038 |
| 169 | Abnormality of the thymus (HP:0000777) | 1.58104060 |
| 170 | Type 2 muscle fiber atrophy (HP:0003554) | 1.57348310 |
| 171 | Areflexia of lower limbs (HP:0002522) | 1.56951710 |
| 172 | Lymphoma (HP:0002665) | 1.56378383 |
| 173 | Respiratory difficulties (HP:0002880) | 1.54317168 |
| 174 | Abnormal ventriculo-arterial connection (HP:0011563) | 1.51926820 |
| 175 | Transposition of the great arteries (HP:0001669) | 1.51926820 |
| 176 | Abnormal connection of the cardiac segments (HP:0011545) | 1.51926820 |
| 177 | Prominent metopic ridge (HP:0005487) | 1.49465627 |
| 178 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.48962331 |
| 179 | Single umbilical artery (HP:0001195) | 1.48962331 |
| 180 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.48962331 |
| 181 | Myelodysplasia (HP:0002863) | 1.48179637 |
| 182 | IgM deficiency (HP:0002850) | 1.46194850 |
| 183 | Myositis (HP:0100614) | 1.45065891 |
| 184 | Abnormality of the aortic arch (HP:0012303) | 1.43764309 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 3.78250968 |
| 2 | ZAK | 3.59918746 |
| 3 | PRPF4B | 3.53032910 |
| 4 | OBSCN | 3.39498435 |
| 5 | MKNK1 | 3.25949723 |
| 6 | STK24 | 3.18940880 |
| 7 | EIF2AK1 | 3.12733053 |
| 8 | SRPK1 | 3.07508063 |
| 9 | PLK4 | 2.66860278 |
| 10 | STK38L | 2.66694981 |
| 11 | MKNK2 | 2.61233270 |
| 12 | SCYL2 | 2.55384396 |
| 13 | MAP3K10 | 2.35395224 |
| 14 | CDK12 | 2.19377860 |
| 15 | ERBB3 | 2.15891096 |
| 16 | BRSK2 | 2.03415098 |
| 17 | CDC7 | 1.98126925 |
| 18 | TRIB3 | 1.93172859 |
| 19 | EIF2AK2 | 1.92599449 |
| 20 | KSR2 | 1.83335174 |
| 21 | MAP3K2 | 1.78264598 |
| 22 | PLK3 | 1.78079598 |
| 23 | BUB1 | 1.73443823 |
| 24 | NEK9 | 1.72568713 |
| 25 | MAP3K13 | 1.69016001 |
| 26 | STK3 | 1.65429547 |
| 27 | NUAK1 | 1.64476899 |
| 28 | JAK1 | 1.60478666 |
| 29 | TRPM7 | 1.59316621 |
| 30 | CLK1 | 1.57476433 |
| 31 | IRAK4 | 1.47857301 |
| 32 | DMPK | 1.44886634 |
| 33 | SMG1 | 1.44442175 |
| 34 | MYLK | 1.44244677 |
| 35 | MAP2K3 | 1.43419426 |
| 36 | STK4 | 1.43359581 |
| 37 | EIF2AK3 | 1.40085509 |
| 38 | TXK | 1.34867807 |
| 39 | MAP3K14 | 1.32253562 |
| 40 | STK10 | 1.31332323 |
| 41 | WEE1 | 1.29325591 |
| 42 | WNK1 | 1.26853536 |
| 43 | KSR1 | 1.26424535 |
| 44 | BTK | 1.26230512 |
| 45 | JAK3 | 1.25005403 |
| 46 | FRK | 1.24391004 |
| 47 | MAP3K12 | 1.24331364 |
| 48 | PIK3CA | 1.23394441 |
| 49 | RPS6KA4 | 1.22928917 |
| 50 | BRD4 | 1.19546244 |
| 51 | EEF2K | 1.18652349 |
| 52 | CSK | 1.16497381 |
| 53 | IRAK3 | 1.15073382 |
| 54 | TTK | 1.14154199 |
| 55 | PBK | 1.12536539 |
| 56 | PLK1 | 1.11105301 |
| 57 | PIM1 | 1.10175878 |
| 58 | ACVR1B | 1.08118547 |
| 59 | BMPR2 | 1.06549669 |
| 60 | PLK2 | 1.05680003 |
| 61 | SYK | 1.05659410 |
| 62 | AKT3 | 1.05566801 |
| 63 | AURKB | 1.04439588 |
| 64 | TTN | 1.02801055 |
| 65 | CHUK | 1.02273165 |
| 66 | BRSK1 | 1.00781599 |
| 67 | PKN2 | 0.98408891 |
| 68 | JAK2 | 0.98303775 |
| 69 | ICK | 0.96565668 |
| 70 | HCK | 0.95529459 |
| 71 | YES1 | 0.94559330 |
| 72 | SGK2 | 0.94046672 |
| 73 | TESK1 | 0.92761802 |
| 74 | TGFBR1 | 0.91626432 |
| 75 | ATR | 0.88963656 |
| 76 | MAP3K1 | 0.88189545 |
| 77 | RAF1 | 0.88118696 |
| 78 | PDGFRB | 0.86478209 |
| 79 | MAPK12 | 0.85986203 |
| 80 | CDK8 | 0.85939295 |
| 81 | VRK1 | 0.84643835 |
| 82 | LIMK1 | 0.84068902 |
| 83 | PIM2 | 0.83830130 |
| 84 | HIPK2 | 0.82901286 |
| 85 | MELK | 0.82069425 |
| 86 | IKBKB | 0.79779610 |
| 87 | SIK3 | 0.79689190 |
| 88 | MARK3 | 0.78790987 |
| 89 | ALK | 0.77967605 |
| 90 | TYK2 | 0.76671345 |
| 91 | NEK6 | 0.76572193 |
| 92 | MAP3K3 | 0.75534564 |
| 93 | TEC | 0.75334127 |
| 94 | PASK | 0.75215498 |
| 95 | NEK1 | 0.75076343 |
| 96 | PDGFRA | 0.75037787 |
| 97 | PDK1 | 0.74565097 |
| 98 | FGFR3 | 0.72310553 |
| 99 | IKBKE | 0.72077631 |
| 100 | CHEK2 | 0.71899013 |
| 101 | FES | 0.69281023 |
| 102 | BLK | 0.66902219 |
| 103 | GRK6 | 0.65220649 |
| 104 | TAF1 | 0.64624155 |
| 105 | MAPK11 | 0.64194838 |
| 106 | RET | 0.63944559 |
| 107 | MAP3K9 | 0.63513478 |
| 108 | NEK2 | 0.61352656 |
| 109 | ATM | 0.60218450 |
| 110 | CSF1R | 0.59479175 |
| 111 | TGFBR2 | 0.58561544 |
| 112 | CSNK2A1 | 0.58107077 |
| 113 | NLK | 0.57601390 |
| 114 | AURKA | 0.57064697 |
| 115 | MARK2 | 0.56229072 |
| 116 | LATS1 | 0.54878509 |
| 117 | MST4 | 0.53621027 |
| 118 | CHEK1 | 0.53610282 |
| 119 | EPHA2 | 0.53510022 |
| 120 | PDPK1 | 0.53301039 |
| 121 | MAP4K1 | 0.51857122 |
| 122 | NME2 | 0.51808103 |
| 123 | MTOR | 0.51256345 |
| 124 | SGK3 | 0.49988498 |
| 125 | RPS6KA6 | 0.48767303 |
| 126 | LCK | 0.48398760 |
| 127 | MAP3K6 | 0.48201393 |
| 128 | RPS6KC1 | 0.47534609 |
| 129 | RPS6KL1 | 0.47534609 |
| 130 | CDK4 | 0.47234625 |
| 131 | ITK | 0.46302435 |
| 132 | CAMKK2 | 0.44612885 |
| 133 | CDK6 | 0.44366465 |
| 134 | MAPKAPK2 | 0.44293475 |
| 135 | BMX | 0.43575401 |
| 136 | CDK7 | 0.42614369 |
| 137 | MAP3K7 | 0.41518566 |
| 138 | CCNB1 | 0.40586960 |
| 139 | BRAF | 0.40503049 |
| 140 | MAP2K1 | 0.40437627 |
| 141 | PIK3CG | 0.40202148 |
| 142 | PAK2 | 0.39666666 |
| 143 | SIK1 | 0.39541923 |
| 144 | RPS6KB2 | 0.39363968 |
| 145 | TSSK6 | 0.38482243 |
| 146 | MAP3K8 | 0.38478372 |
| 147 | RPS6KB1 | 0.37623901 |
| 148 | ILK | 0.36975776 |
| 149 | MOS | 0.36228469 |
| 150 | CDK2 | 0.35903212 |
| 151 | LRRK2 | 0.34180528 |
| 152 | RPS6KA5 | 0.34067694 |
| 153 | ZAP70 | 0.33924652 |
| 154 | MAP3K5 | 0.33893424 |
| 155 | MAPK10 | 0.33751154 |
| 156 | TLK1 | 0.33124457 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 3.28272710 |
| 2 | Mismatch repair_Homo sapiens_hsa03430 | 3.23727122 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 3.16247538 |
| 4 | Cell cycle_Homo sapiens_hsa04110 | 2.59893241 |
| 5 | Homologous recombination_Homo sapiens_hsa03440 | 2.54676521 |
| 6 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.54191421 |
| 7 | Base excision repair_Homo sapiens_hsa03410 | 2.51628784 |
| 8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.36071484 |
| 9 | RNA polymerase_Homo sapiens_hsa03020 | 2.35293736 |
| 10 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 2.32981919 |
| 11 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.32587877 |
| 12 | RNA transport_Homo sapiens_hsa03013 | 2.29531167 |
| 13 | Spliceosome_Homo sapiens_hsa03040 | 2.21304013 |
| 14 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.15438842 |
| 15 | Basal transcription factors_Homo sapiens_hsa03022 | 1.96912264 |
| 16 | RNA degradation_Homo sapiens_hsa03018 | 1.94955112 |
| 17 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.93459337 |
| 18 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.86731407 |
| 19 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.75898480 |
| 20 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.75157617 |
| 21 | Platelet activation_Homo sapiens_hsa04611 | 1.73596557 |
| 22 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.64769880 |
| 23 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.62427661 |
| 24 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.55222307 |
| 25 | Glioma_Homo sapiens_hsa05214 | 1.51952991 |
| 26 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.51146152 |
| 27 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.51044736 |
| 28 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.49449174 |
| 29 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.48387832 |
| 30 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.40450743 |
| 31 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.40278020 |
| 32 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.36736673 |
| 33 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.32334465 |
| 34 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.31765514 |
| 35 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.31491344 |
| 36 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.28735957 |
| 37 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.27784202 |
| 38 | Measles_Homo sapiens_hsa05162 | 1.21702834 |
| 39 | Viral myocarditis_Homo sapiens_hsa05416 | 1.21695446 |
| 40 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.20578226 |
| 41 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.20530054 |
| 42 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.19943861 |
| 43 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.19122716 |
| 44 | Ribosome_Homo sapiens_hsa03010 | 1.18902731 |
| 45 | Adherens junction_Homo sapiens_hsa04520 | 1.14383816 |
| 46 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.14344681 |
| 47 | Long-term potentiation_Homo sapiens_hsa04720 | 1.13978827 |
| 48 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.13434455 |
| 49 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.11171213 |
| 50 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.09139183 |
| 51 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.08508952 |
| 52 | Tuberculosis_Homo sapiens_hsa05152 | 1.08498553 |
| 53 | Legionellosis_Homo sapiens_hsa05134 | 1.08005199 |
| 54 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.06881759 |
| 55 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.04695847 |
| 56 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.04077576 |
| 57 | Leishmaniasis_Homo sapiens_hsa05140 | 1.02598333 |
| 58 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.01662236 |
| 59 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.01018169 |
| 60 | Protein export_Homo sapiens_hsa03060 | 0.98991909 |
| 61 | Purine metabolism_Homo sapiens_hsa00230 | 0.98900258 |
| 62 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.98758328 |
| 63 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.98137492 |
| 64 | HTLV-I infection_Homo sapiens_hsa05166 | 0.98027490 |
| 65 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.97297027 |
| 66 | Thyroid cancer_Homo sapiens_hsa05216 | 0.95561460 |
| 67 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.95544556 |
| 68 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.94973221 |
| 69 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.93961742 |
| 70 | Allograft rejection_Homo sapiens_hsa05330 | 0.93210777 |
| 71 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.93105255 |
| 72 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.89383496 |
| 73 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.87689043 |
| 74 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.86724329 |
| 75 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.86352963 |
| 76 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.86311897 |
| 77 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.86222113 |
| 78 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.85970618 |
| 79 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.85181755 |
| 80 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.83446135 |
| 81 | Influenza A_Homo sapiens_hsa05164 | 0.81221468 |
| 82 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.81188757 |
| 83 | Hepatitis C_Homo sapiens_hsa05160 | 0.80867771 |
| 84 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.79970157 |
| 85 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.79623975 |
| 86 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.78503872 |
| 87 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.78307335 |
| 88 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.77702185 |
| 89 | Apoptosis_Homo sapiens_hsa04210 | 0.76129293 |
| 90 | Shigellosis_Homo sapiens_hsa05131 | 0.75071505 |
| 91 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.73712803 |
| 92 | Bladder cancer_Homo sapiens_hsa05219 | 0.72527927 |
| 93 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.71705615 |
| 94 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.71523293 |
| 95 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.71497574 |
| 96 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.70919206 |
| 97 | Endocytosis_Homo sapiens_hsa04144 | 0.70305860 |
| 98 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.70233724 |
| 99 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.69596764 |
| 100 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.68996547 |
| 101 | Melanoma_Homo sapiens_hsa05218 | 0.68448036 |
| 102 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.68080539 |
| 103 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.67570629 |
| 104 | Prostate cancer_Homo sapiens_hsa05215 | 0.67176539 |
| 105 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.66377851 |
| 106 | Hepatitis B_Homo sapiens_hsa05161 | 0.66104160 |
| 107 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.65759622 |
| 108 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.64881758 |
| 109 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.64340868 |
| 110 | Insulin resistance_Homo sapiens_hsa04931 | 0.64324891 |
| 111 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.61887445 |
| 112 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.60905808 |
| 113 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.60426327 |
| 114 | Amoebiasis_Homo sapiens_hsa05146 | 0.59400786 |
| 115 | Asthma_Homo sapiens_hsa05310 | 0.59308469 |
| 116 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.58972005 |
| 117 | Galactose metabolism_Homo sapiens_hsa00052 | 0.58662312 |
| 118 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.58267074 |
| 119 | Huntingtons disease_Homo sapiens_hsa05016 | 0.56733873 |
| 120 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.56249610 |
| 121 | Malaria_Homo sapiens_hsa05144 | 0.56032088 |
| 122 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.55972304 |
| 123 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.55562115 |
| 124 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.55448843 |
| 125 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.55339776 |
| 126 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.54600108 |
| 127 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.53728438 |
| 128 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.52182819 |
| 129 | Tight junction_Homo sapiens_hsa04530 | 0.52116727 |
| 130 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.52076385 |
| 131 | Circadian rhythm_Homo sapiens_hsa04710 | 0.50898739 |
| 132 | Focal adhesion_Homo sapiens_hsa04510 | 0.50395186 |
| 133 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.49656610 |
| 134 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.49570483 |
| 135 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.49142547 |
| 136 | Endometrial cancer_Homo sapiens_hsa05213 | 0.48423265 |
| 137 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.46736437 |
| 138 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.45366718 |
| 139 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.44968231 |
| 140 | Pathways in cancer_Homo sapiens_hsa05200 | 0.42559494 |
| 141 | Colorectal cancer_Homo sapiens_hsa05210 | 0.42359654 |
| 142 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.40598082 |
| 143 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.39969618 |
| 144 | Parkinsons disease_Homo sapiens_hsa05012 | 0.39670817 |
| 145 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.39222546 |
| 146 | Pertussis_Homo sapiens_hsa05133 | 0.38177343 |
| 147 | Salmonella infection_Homo sapiens_hsa05132 | 0.37379241 |
| 148 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.36575236 |
| 149 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.35371938 |
| 150 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.35318512 |

